Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
Apister Lifesciences Private Limited, is an unlisted private company incorporated on 01 May, 2017. It is classified as a private limited company and is located in , Gujarat. It's authorized share capital is INR 5.00 lac and the total paid-up capital is INR 1.00 lac.
Apister Lifesciences's operating revenue range is INR 100 cr - 500 cr for the financial year ending on 31 March, 2024. It's EBITDA has decreased by 25.79% over the previous year. At the same time, it's book networth has increased by 29.3%.
Read more
** All rupee values in INR crores.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
** Delivery timelines are on best-effort basis during working hours. Filings 3-4 hours. Reports 24-48 hours.
* INR 349 for 20+ credits purchase
1 credit = one company dashboard
| State | Type | Address |
|---|
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Ami Hemal Patel | 02398397 | 0 years |
| Director | Hemal Naranbhai Patel | 02456081 | 1 years |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Financials upto March 2024 available in Tofler Pro
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
As per information available, the company has no registered charges.
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| MILIKEM PHARMACEUTICALS PRIVATE LIMITED |
Strike Off
|
1.0 L | 2 | Maharashtra |
| D RAJA PHARMACEUTICALS LLP |
Active
|
1.0 L | 1 | Gujarat |
| MAHARSHI PHARMA CHEM PRIVATE LIMITED |
Active
|
1.0 Cr | 1 | Gujarat |
| VIDMAN HEALTHCARE PRIVATE LIMITED |
Active
|
1.0 L | 1 | |
| AMIGEN BIOSCIENCES PRIVATE LIMITED |
Active
|
50,000.0 | 1 | |
| GENPEP PHARMACEUTICALS PRIVATE LIMITED |
Active
|
5.0 Cr | 1 |
Read more
The incorporation date of APISTER LIFESCIENCES PRIVATE LIMITED is 01 May, 2017
The authorized share capital of APISTER LIFESCIENCES PRIVATE LIMITED is INR ₹ 5.0 L.
The paid-up capital of APISTER LIFESCIENCES PRIVATE LIMITED is INR ₹ 1.0 L.
The registered address of APISTER LIFESCIENCES PRIVATE LIMITED is BLOCK - A, SHOP -114, GANESH MERIDIAN OPP. HIGH COURT, S.G. HIGHWAY, GHATLODIA, Ahmedabad, AHMEDABAD, Gujarat, India, 380061 - 380061
The CIN number of APISTER LIFESCIENCES PRIVATE LIMITED is U24304GJ2017PTC097161.